Sarbjit S Saini

4PUBLICATIONS
8CO-AUTHORS
PharmacogenomicsAllergyCatalysis and mechanisms of reactionsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 26, 2022
Pharmacokinetic equivalence of CT-P39 and reference omalizumab in healthy individuals: A randomised, double-blind, parallel-group, Phase 1 trial.

Marcus Maurer, Sarbjit S Saini, Kristi McLendon

|Aug 25, 2021
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.

Jonathan Corren, Sarbjit S Saini, Remi Gagnon

|Jun 08, 2019
Emerging Therapies in Chronic Spontaneous Urticaria.

Taek Ki Min, Sarbjit S Saini

|Sep 01, 2018
Very rarely chronic urticaria can be caused by cancer and if so, resolves with its cure.

D Larenas-Linnemann, S S Saini, A A Azamar-Jácome

Pageof 1

Frequent Collaborators

2 joint publications

Marcus Maurer

1 joint publications

D Larenas-Linnemann

1 joint publications

A A Azamar-Jácome

1 joint publications

E Jensen-Jarolim